Revisiting biomarker discovery by plasma proteomics

Philipp E Geyer, Lesca M Holdt, Daniel Teupser, Matthias Mann

    227 Citations (Scopus)
    86 Downloads (Pure)

    Abstract

    Clinical analysis of blood is the most widespread diagnostic procedure in medicine, and blood biomarkers are used to categorize patients and to support treatment decisions. However, existing biomarkers are far from comprehensive and often lack specificity and new ones are being developed at a very slow rate. As described in this review, mass spectrometry (MS)-based proteomics has become a powerful technology in biological research and it is now poised to allow the characterization of the plasma proteome in great depth. Previous "triangular strategies" aimed at discovering single biomarker candidates in small cohorts, followed by classical immunoassays in much larger validation cohorts. We propose a "rectangular" plasma proteome profiling strategy, in which the proteome patterns of large cohorts are correlated with their phenotypes in health and disease. Translating such concepts into clinical practice will require restructuring several aspects of diagnostic decision-making, and we discuss some first steps in this direction.

    Original languageEnglish
    Article number942
    JournalMolecular Systems Biology
    Volume13
    Issue number9
    Number of pages16
    ISSN1744-4292
    DOIs
    Publication statusPublished - 26 Sept 2017

    Keywords

    • Journal Article
    • Review

    Fingerprint

    Dive into the research topics of 'Revisiting biomarker discovery by plasma proteomics'. Together they form a unique fingerprint.

    Cite this